The Association Between Patient Reported Outcomes of Spinal Surgery and Societal Costs: A Register Based Study.


Journal

Spine
ISSN: 1528-1159
Titre abrégé: Spine (Phila Pa 1976)
Pays: United States
ID NLM: 7610646

Informations de publication

Date de publication:
Sep 2019
Historique:
pubmed: 16 4 2019
medline: 7 1 2020
entrez: 16 4 2019
Statut: ppublish

Résumé

Retrospective register-based study using Swedish registers and data prospectively collected in quality register Swespine. Analyze the association of societal costs and spine surgery outcome in low back pain (LBP) patients based on patient reported outcome measures (PROMs). Studies show that LBP has a substantial impact on societal cost. There are indications that the burden diverges over different patient groups, but little is known about cost patterns in relation to PROMs of LBP surgery. We utilized a database with data from six registers. All lumbar spine surgery patients registered in Swespine 2000 to 2012 were identified. Swespine collects PROMs Global Assessment of pain improvement (GA), Oswestry Disability Index (ODI), Visual Analog Scale (VAS), and EuroQol five-dimension scale (EQ-5D). A literature search was conducted to identify threshold changes in ODI, VAS, and EQ-5D representing a significant improvement or deterioration as defined by the minimal clinically important difference (MCID). We categorized patients into groups by their GA response at 2-year follow-up and estimated mean changes in ODI, VAS, and EQ-5D for each group. These changes were compared with the MCID thresholds to determine a GA-anchored classification of surgical outcomes. Costs consisted of out/inpatient care, sick leave, early retirement, and pharmaceuticals. In total, 12,350 patients were included. GA 1-2 ("pain has disappeared"/"pain is much improved") were labeled successful surgery outcomes (67%), GA 3 ("pain somewhat improved"), undetermined (16%), and GA 4-5 ("no change in pain"/"pain has worsened") unsuccessful (17%). Costs of the unsuccessful and undetermined were higher than of the successful during the entire study period, with differences increasing markedly post-surgery. For the successful, a downward cost trend was observed; costs almost returned to the level observed 3 years pre-surgery. No such trend was observed in the other groups. Identifying patients with higher probability of responding to surgery could lead to improved health and substantial societal cost savings. 3.

Sections du résumé

STUDY DESIGN METHODS
Retrospective register-based study using Swedish registers and data prospectively collected in quality register Swespine.
OBJECTIVE OBJECTIVE
Analyze the association of societal costs and spine surgery outcome in low back pain (LBP) patients based on patient reported outcome measures (PROMs).
SUMMARY OF BACKGROUND DATA BACKGROUND
Studies show that LBP has a substantial impact on societal cost. There are indications that the burden diverges over different patient groups, but little is known about cost patterns in relation to PROMs of LBP surgery.
METHODS METHODS
We utilized a database with data from six registers. All lumbar spine surgery patients registered in Swespine 2000 to 2012 were identified. Swespine collects PROMs Global Assessment of pain improvement (GA), Oswestry Disability Index (ODI), Visual Analog Scale (VAS), and EuroQol five-dimension scale (EQ-5D). A literature search was conducted to identify threshold changes in ODI, VAS, and EQ-5D representing a significant improvement or deterioration as defined by the minimal clinically important difference (MCID). We categorized patients into groups by their GA response at 2-year follow-up and estimated mean changes in ODI, VAS, and EQ-5D for each group. These changes were compared with the MCID thresholds to determine a GA-anchored classification of surgical outcomes. Costs consisted of out/inpatient care, sick leave, early retirement, and pharmaceuticals.
RESULTS RESULTS
In total, 12,350 patients were included. GA 1-2 ("pain has disappeared"/"pain is much improved") were labeled successful surgery outcomes (67%), GA 3 ("pain somewhat improved"), undetermined (16%), and GA 4-5 ("no change in pain"/"pain has worsened") unsuccessful (17%). Costs of the unsuccessful and undetermined were higher than of the successful during the entire study period, with differences increasing markedly post-surgery. For the successful, a downward cost trend was observed; costs almost returned to the level observed 3 years pre-surgery. No such trend was observed in the other groups.
CONCLUSION CONCLUSIONS
Identifying patients with higher probability of responding to surgery could lead to improved health and substantial societal cost savings.
LEVEL OF EVIDENCE METHODS
3.

Identifiants

pubmed: 30985570
doi: 10.1097/BRS.0000000000003050
pii: 00007632-201909150-00015
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1309-1317

Références

Hoy D, March L, Brooks P, et al. Measuring the global burden of low back pain. Best Pract Res Clin Rheumatol 2010; 24:155–165.
Andersson GB. Epidemiological features of chronic low-back pain. Lancet 1999; 354:581–585.
Stockholm Spine Center. Gemensamt vårdprogram för ländryggssmärta [Care Guideline for Low Back Pain]; 2008. Available at: http://stockholm.spinecenter.se/documents/Files/vrdprogram_lndrygg.pdf. Accessed February 14, 2019
Bhangle SD, Sapru S, Panush RS. Back pain made simple: an approach based on principles and evidence. Cleve Clin J Med 2009; 76:393–399.
Dagenais S, Caro J, Haldeman S. A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J 2008; 8:8–20.
Maetzel A, Li L. The economic burden of low back pain: a review of studies published between 1996 and 2001. Best Pract Res Clin Rheumatol 2002; 16:23–30.
Montazeri A, Mousavi S. Quality of life and low back pain. Handbook of Disease Burdens and Quality of Life Measures. 2010; New York, NY: Springer, 3979–3994.
Buchbinder R, Blyth FM, March LM, et al. Placing the global burden of low back pain in context. Best Pract Res Clin Rheumatol 2013; 27:575–589.
Chou R, Baisden J, Carragee EJ, et al. Surgery for low back pain: a review of the evidence for an American Pain Society Clinical Practice Guideline. Spine (Phila Pa 1976) 2009; 34:1094–1109.
Jonsson E, Olafsson G, Fritzell P, et al. A Profile of Low Back Pain. Spine 2017; 42:1302–1310.
Svensk Ryggkirurgisk förening. Swespine Årsrapport 2016 [Annual report 2016]; 2016.
Mannion AF, Balague F, Pellise F, et al. Pain measurement in patients with low back pain. Nat Clin Pract Rheumatol 2007; 3:610–618.
Fairbank JC, Couper J, Davies JB, et al. The Oswestry low back pain disability questionnaire. Physiotherapy 1980; 66:271–273.
Fairbank JC. The use of revised Oswestry Disability Questionnaire. Spine (Phila Pa 1976) 2000; 25:2846–2847.
Fairbank JC. Oswestry disability index. J Neurosurg Spine 2014; 20:239–241.
Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35:1095–1108.
Hagg O, Fritzell P, Nordwall A, et al. The clinical importance of changes in outcome scores after treatment for chronic low back pain. Eur Spine J 2003; 12:12–20.
Chapman JR, Norvell DC, Hermsmeyer JT, et al. Evaluating common outcomes for measuring treatment success for chronic low back pain. Spine (Phila Pa 1976) 2011; 36 (21 suppl):S54–S68.
Solberg T, Johnsen LG, Nygaard OP, et al. Can we define success criteria for lumbar disc surgery?: estimates for a substantial amount of improvement in core outcome measures. Acta Orthop 2013; 84:196–201.
Parai C, Hagg O, Lind B, et al. The value of patient global assessment in lumbar spine surgery: an evaluation based on more than 90,000 patients. Eur Spine J 2018; 27:554–563.
Region Västra Götaland, Regional price list 2016.
Karolinska University Hospital, Regional price list 2016.
Region South, Regional price list 2016.
Statistics Sweden. Average monthly wage [Internet]. Available at: http://www.statistikdatabasen.scb.se/2014. Accessed February 14, 2019.
Parker SL, Mendenhall SK, Shau DN, et al. Minimum clinically important difference in pain, disability, and quality of life after neural decompression and fusion for same-level recurrent lumbar stenosis: understanding clinical versus statistical significance. J Neurosurg Spine 2012; 16:471–478.
Haugen AJ, Grovle L, Brox JI, et al. Estimates of success in patients with sciatica due to lumbar disc herniation depend upon outcome measure. Eur Spine J 2011; 20:1669–1675.
Ostelo RW, de Vet HC. Clinically important outcomes in low back pain. Best Pract Res Clin Rheumatol 2005; 19:593–607.
Iversen T, Solberg TK, Wilsgaard T, et al. Outcome prediction in chronic unilateral lumbar radiculopathy: prospective cohort study. BMC Musculoskelet Disord 2015; 16:17.
Glassman SD, Copay AG, Berven SH, et al. Defining substantial clinical benefit following lumbar spine arthrodesis. J Bone Joint Surg Am 2008; 90:1839–1847.
Maughan EF, Lewis JS. Outcome measures in chronic low back pain. Eur Spine J 2010; 19:1484–1494.
Cleland JA, Whitman JM, Houser JL, et al. Psychometric properties of selected tests in patients with lumbar spinal stenosis. Spine J 2012; 12:921–931.
Lauridsen HH, Manniche C, Korsholm L, et al. What is an acceptable outcome of treatment before it begins? Methodological considerations and implications for patients with chronic low back pain. Eur Spine J 2009; 18:1858–1866.
Fritz JM, Irrgang JJ. A comparison of a modified Oswestry Low Back Pain Disability Questionnaire and the Quebec Back Pain Disability Scale. Phys Ther 2001; 81:776–788.
Hagg O, Fritzell P, Oden A, et al. Simplifying outcome measurement: evaluation of instruments for measuring outcome after fusion surgery for chronic low back pain. Spine (Phila Pa 1976) 2002; 27:1213–1222.
Täckningsgrader 2015 Jämförelser mellan nationella kvalitetsregister och hälsodataregistren (Coverage 2015 Comparison between national quality registers and the health data registers). Available at: http://www.socialstyrelsen.se/publikationer2015/2015-12-8. The National Board of Health and Welfare; 2015. Accessed February 14, 2019.

Auteurs

Amanda Hansson-Hedblom (A)

Quantify Research, Stockholm, Sweden.

Emma Jonsson (E)

Quantify Research, Stockholm, Sweden.

Peter Fritzell (P)

Department of Surgical Sciences, Uppsala University Hospital, Sweden.
Futurum-Academy for Health and Care, Ryhov Jönköping, Sweden.

Olle Hägg (O)

Spine Center Göteborg, Gothenburg, Sweden.

Fredrik Borgström (F)

Quantify Research, Stockholm, Sweden.
Department of Learning, Informatics, Management and Ethics/Medical Management Centrum, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH